Phase 3 Study of Zigakibart (BION-1301) in Adults with IgA Nephropathy
- Substances:Zigakibart
Germany- Participants:18–64 years · 65+ years
- Substances:Zigakibart
- Sponsor:Novartis Pharma AG
Rare diseases
Investigational molecules
Locations
Back to Germany251 clinical trials in Magdeburg, Germany across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
GermanyBaricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis
GermanyStudy of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer's Disease
GermanyA study testing trontinemab compared to placebo in patients with early Alzheimer's disease including mild cognitive impairment and mild dementia
GermanyA study testing DII235 compared to placebo in adults with high lipoprotein(a) levels to reduce heart disease risk
GermanyLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
GermanyStudy on Long-Term Effects and Safety of Herpes Zoster Vaccine with Recombinant Varicella Zoster Virus Glycoprotein E in Older Adults
GermanyStudy on the Effectiveness and Safety of Zasocitinib (TAK-279) for Patients with Active Psoriatic Arthritis with Previous Biologic Treatment
GermanyStudy on GSK5784283 for Adults Aged 18-75 with Uncontrolled Asthma
GermanyStudy of SAR441566 compared to placebo for adults with moderate to severe Crohn's disease
GermanyStudy on Dupilumab for Itch Relief in Adults with Lichen Simplex Chronicus (Neurodermatitis)
GermanyStudy of Vosoritide for Children with Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome Not Responding to Growth Hormone
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on innovative treatments for various cancer types, including breast cancer, lymphoma, and pancreatic cancer. Studies evaluate new therapeutic approaches and combination treatments.
Particular emphasis on targeted therapies and immunotherapy approaches for better patient outcomes.
Research focusing on chronic skin conditions and innovative treatments for psoriasis and other dermatological disorders. Multiple trials investigating new therapeutic options.
Studies aim to improve quality of life through advanced therapeutic approaches.
Investigations into treatments for cardiovascular disease and metabolic disorders, including innovative approaches for managing hypertriglyceridemia and diabetes.
Focus on preventive strategies and novel therapeutic interventions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.